Field & Main Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32K | Hold |
1,140
| – | – | 0.01% | 194 |
|
|
2025
Q4 | $28.4K | Hold |
1,140
| – | – | 0.01% | 196 |
|
|
2025
Q3 | $29K | Sell |
1,140
-175
| -13% | -$4.32K | 0.01% | 192 |
|
|
2025
Q2 | $31.9K | Sell |
1,315
-150
| -10% | -$3.5K | 0.01% | 185 |
|
|
2025
Q1 | $37.1K | Buy |
1,465
+325
| +29% | +$8.5K | 0.01% | 180 |
|
|
2024
Q4 | $30.2K | Hold |
1,140
| – | – | 0.01% | 187 |
|
|
2024
Q3 | $33K | Sell |
1,140
-425
| -27% | -$12.4K | 0.01% | 184 |
|
|
2024
Q2 | $43.8K | Sell |
1,565
-125
| -7% | -$3.44K | 0.02% | 176 |
|
|
2024
Q1 | $46.9K | Sell |
1,690
-4,875
| -74% | -$135K | 0.02% | 172 |
|
|
2023
Q4 | $189K | Sell |
6,565
-4,512
| -41% | -$136K | 0.08% | 127 |
|
|
2023
Q3 | $367K | Sell |
11,077
-638
| -5% | -$22.6K | 0.17% | 104 |
|
|
2023
Q2 | $430K | Buy |
11,715
+165
| +1% | +$6.42K | 0.24% | 89 |
|
|
2023
Q1 | $471K | Buy |
11,550
+1,035
| +10% | +$44.7K | 0.28% | 86 |
|
|
2022
Q4 | $539K | Buy |
10,515
+975
| +10% | +$46.7K | 0.35% | 78 |
|
|
2022
Q3 | $417K | Buy |
9,540
+100
| +1% | +$4.86K | 0.28% | 92 |
|
|
2022
Q2 | $495K | Buy |
9,440
+3,050
| +48% | +$155K | 0.32% | 85 |
|
|
2022
Q1 | $331K | Buy |
6,390
+1,325
| +26% | +$68.7K | 0.2% | 95 |
|
|
2021
Q4 | $299K | Hold |
5,065
| – | – | 0.17% | 106 |
|
|
2021
Q3 | $218K | Sell |
5,065
-200
| -4% | -$8.86K | 0.14% | 110 |
|
|
2021
Q2 | $206K | Buy |
5,265
+50
| +1% | +$1.94K | 0.13% | 112 |
|
|
2021
Q1 | $189K | Sell |
5,215
-50
| -0.9% | -$1.77K | 0.14% | 110 |
|
|
2020
Q4 | $194K | Sell |
5,265
-584
| -10% | -$21.4K | 0.14% | 101 |
|
|
2020
Q3 | $204K | Sell |
5,849
-210
| -3% | -$7.36K | 0.16% | 96 |
|
|
2020
Q2 | $188K | Buy |
+6,059
| New | +$206K | 0.16% | 98 |
|
|
2019
Q4 | $246K | Sell |
6,613
-1,291
| -16% | -$46K | 0.2% | 88 |
|
|
2019
Q3 | $269K | Sell |
7,904
-3,057
| -28% | -$111K | 0.24% | 87 |
|
|
2019
Q2 | $450K | Buy |
10,961
+1,187
| +12% | +$47.1K | 0.41% | 73 |
|
|
2019
Q1 | $394K | Buy |
+9,774
| New | +$391K | 0.37% | 78 |
|
|
2018
Q3 | $293K | Hold |
7,007
| – | – | 0.26% | 90 |
|
|
2018
Q2 | $265K | Buy |
7,007
+104
| +2% | +$3.55K | 0.24% | 93 |
|
|
2018
Q1 | $232K | Buy |
6,903
+405
| +6% | +$13.9K | 0.23% | 99 |
|
|
2017
Q4 | $223K | Buy |
+6,498
| New | +$222K | 0.21% | 101 |
|
|
2015
Q2 | $331K | Sell |
10,405
-1,159
| -10% | -$37.8K | 0.31% | 92 |
|
|
2015
Q1 | $382K | Buy |
11,564
+527
| +5% | +$16.8K | 0.35% | 89 |
|
|
2014
Q4 | $326K | Buy |
11,037
+158
| +1% | +$4.53K | 0.3% | 88 |
|
|
2014
Q3 | $305K | Buy |
10,879
+369
| +4% | +$10.4K | 0.29% | 90 |
|
|
2014
Q2 | $296K | Sell |
10,510
-211
| -2% | -$6.01K | 0.28% | 88 |
|
|
2014
Q1 | $327K | Sell |
10,721
-213
| -2% | -$6.35K | 0.32% | 85 |
|
|
2013
Q4 | $318K | Buy |
+10,934
| New | +$318K | 0.31% | 88 |
|
Other funds holding PFE
VCM
VPM
Field & Main Bank's PFE Position: Q1 2026 in Review
Field & Main Bank held its Pfizer (PFE) position steady in Q1 2026 at 1,140 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #194.
Field & Main Bank first reported a position in PFE in Q4 2013 and has held it in 39 quarters since. The position peaked at $539K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Field & Main Bank held 1,140 shares of Pfizer worth $32K as of Q1 2026.
- Field & Main Bank left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.01% of Field & Main Bank's portfolio in Q1 2026, its #194 holding.
- Field & Main Bank first reported a position in Pfizer in Q4 2013 and has held it in 39 quarters since.
- Field & Main Bank's Pfizer position peaked at $539K in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.